company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9709146.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9709146.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57009.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-635381.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3131045.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7156473.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7156473.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60849.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-200000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-260849.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-260849.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4864714.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2552608.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2010.0,Q4,2010-07-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1339.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12111919.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12111919.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,87171.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,833608.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2914487.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14105627.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14105627.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-166757.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-750000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-916757.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-916757.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87739893.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6175723.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,93915616.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,93915616.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78893232.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q1,2010-10-01,2010-12-31,2012-02-08 16:27:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14465588.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14465588.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,90058.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,951208.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-437675.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13861997.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13861997.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-172528.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-750175.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-922703.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-922703.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,167046.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q2,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14617654.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16065560.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16065560.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117431.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,344688.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1098018.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14505423.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14505423.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-511315.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1500175.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1650175.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-661315.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-661315.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3405380.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3405380.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3416710.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q3,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11750028.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17988496.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17988496.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,143185.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1658220.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2138849.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14048242.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14048242.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-972755.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1651389.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1650175.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-973969.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-973969.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3112017.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,167069.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3279086.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3267756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2011.0,Q4,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11754455.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15946157.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15946157.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,142010.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1162037.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2984928.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17627038.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17627038.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50013.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2617.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-52630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-52630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3097324.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8207987.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11305311.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11305311.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6374357.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q1,2011-10-01,2011-12-31,2012-02-08 16:27:39+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17042159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17042159.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194095.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1234250.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2629104.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12984710.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12984710.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-739481.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50503.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-789984.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-789984.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6965672.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,343178.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7308850.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7308850.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6465844.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q2,2012-01-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15030214.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15030214.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,174453.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,234145.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-325215.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14946831.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14946831.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,35021.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50540.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15519.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15519.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29986909.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29986909.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29986909.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q3,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15024559.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11725470.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11725470.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,189442.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,213000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2246568.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3022961.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12099421.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12099421.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58527.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-340.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58867.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58867.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29615000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-29406074.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,208930.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,208930.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11949358.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,649000.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2012.0,Q4,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12076082.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12076082.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,199115.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1095847.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1899336.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12680456.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12680456.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-179661.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1802.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-181463.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-181463.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26131.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q1,2012-10-01,2012-12-31,2013-02-08 13:05:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12835788.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16526701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16526701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,209146.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2427355.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4274600.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9615600.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9615600.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-100323.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1711.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-102034.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-102034.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19101955.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1558618.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20660573.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20634442.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10916808.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q2,2013-01-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11424630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11424630.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,209333.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,475916.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,984306.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3224054.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12979129.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12978850.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39624.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-110644.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150268.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150268.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-8934.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,300558.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,291624.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,291624.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q3,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12837494.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35448450.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35448450.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,208888.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-475916.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2142488.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3425948.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30147042.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30147321.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128690.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-200718.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,401550.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,72142.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,72142.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29659785.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,652535.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30312320.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30312320.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2013.0,Q4,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,237141.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10946537.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10946537.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,222210.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,120179.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1388117.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-564701.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9780732.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9780732.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1259920.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-350910.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1610830.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1610830.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30222.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30222.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30222.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11361340.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,671250.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q1,2013-10-01,2013-12-31,2014-02-06 13:29:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12677756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12677756.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287019.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,113712.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2010233.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5464012.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15730804.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15730804.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-963800.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-779.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-964579.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-964579.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2708106.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29304970.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,88844.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26685708.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26685708.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9990325.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q2,2014-01-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,651152.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12698763.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12698763.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,294376.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,103655.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1579414.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5361874.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16083192.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16083192.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-243353.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1482.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-237635.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-237635.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2769153.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,49085972.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1088427.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47405246.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47405246.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31084419.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q3,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,590105.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14112944.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14112944.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,598395.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,63454.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2060236.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4331587.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7059272.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7059272.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-590927.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-829.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-200.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-591956.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-591956.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-24522741.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,216963058.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2108507.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,194548824.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,194548824.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,186897596.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2338493.0
"Avanir Pharmaceuticals, Inc.",AVNR,,0000858803,2014.0,Q4,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-200.0
